Turnstone Biologics (NASDAQ:TSBX – Get Free Report) issued its earnings results on Wednesday. The company reported ($0.92) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.84) by ($0.08), Zacks reports.
Turnstone Biologics Stock Down 61.9 %
Shares of TSBX stock traded down $1.35 during trading hours on Thursday, reaching $0.83. The company’s stock had a trading volume of 5,716,627 shares, compared to its average volume of 189,268. Turnstone Biologics has a fifty-two week low of $0.80 and a fifty-two week high of $12.16. The company has a market capitalization of $19.20 million and a price-to-earnings ratio of -0.12. The firm’s 50 day simple moving average is $2.52 and its 200-day simple moving average is $2.81.
Turnstone Biologics Company Profile
See Also
- Five stocks we like better than Turnstone Biologics
- Are Penny Stocks a Good Fit for Your Portfolio?
- Michael Burry’s Alibaba Bet and the Broader Market Implications
- How to Use the MarketBeat Excel Dividend Calculator
- Jeff Brown’s Exegesis AI Stock Picks
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Warren Buffett’s Bet: Why Berkshire Hathaway Bought Ulta Stock
Receive News & Ratings for Turnstone Biologics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Turnstone Biologics and related companies with MarketBeat.com's FREE daily email newsletter.